Business Context and Reporting Period
This Form 8-K Current Report was filed by LifeMD, Inc. (formerly Conversion Labs, Inc.) on February 18, 2021. The report details a corporate name change and a corresponding change to the company's stock trading symbol on The Nasdaq Stock Market LLC.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and securities identification changes rather than financial performance.
Material Changes
- Corporate Name: The company changed its name from "Conversion Labs, Inc." to "LifeMD, Inc." effective February 19, 2021.
- Trading Symbol: The trading symbol for the company's common stock changed to "LFMD" effective February 22, 2021.
- CUSIP Number: The new CUSIP number is 53216B104.
- Shareholder Rights: The name change does not affect the rights of the company's security holders and did not require stockholder approval under Delaware General Corporation Law.
Guidance, Outlook, and Risks
The filing contains no management commentary regarding financial guidance, future outlook, risks, contingencies, or unusual items. The document serves solely to disclose the administrative changes to the company's identity and trading information.
Investor Verification Checklist
- Verify the new trading symbol "LFMD" on The Nasdaq Stock Market LLC effective February 22, 2021.
- Confirm the updated CUSIP number 53216B104 for the common stock.
- Review the Certificate of Amendment (Exhibit 3.1) to confirm the legal name change to LifeMD, Inc.
- Note that no financial data is included in this specific filing; refer to recent 10-K or 10-Q filings for financial metrics.